Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

Psoriasis News

the latest news from ipc, industry and others

The International Psoriasis Council is pleased to welcome AnaptysBio as a 2022 Bronze Level Corporate Member. AnaptysBio, based in San Diego, California, is a clinical-stage biotechnology company developing first-in-class immunology therapeutic product candidates for patients. They are focused on emerging immune control mechanisms applicable to inflammation and immuno-oncology indications. “We are extremely pleased to welcome AnaptysBio to the IPC family and look forward to working with them to improve the care of people with psoriasis worldwide through education, research, and advocacy,” said IPC CEO Christy Langan.

Learn more about AnaptysBio.

Stay informed

Join the email list to receive the latest information on psoriasis meetings, manuscripts and research.

now available

COVID-19 Psoriasis Resource Center

Information from around the world on psoriasis and coronavirus to assist dermatologists and the patients they serve

explore now


on SARS-CoV-2 Vaccines and Psoriasis

Six key take-aways that physicians and other healthcare practitioners should consider when administering the SARS-CoV-2 vaccine to psoriasis patients.


We use cookies on this site to enhance your online experience. By continuing to use this site, you agree to accept cookies.